Ranbaxy Bids For Second Look In Lipitor Feud

Law360, New York (August 17, 2006, 12:00 AM EDT) -- Swiping back in the battle over Pfizer Inc.’s Lipitor, Indian drug maker Ranbaxy Laboratories Ltd. on Wednesday asked a U.S. appeals court to reconsider part of a ruling that would block a generic version of the cholesterol medicine from hitting the market until 2010.

On August 2, the U.S. Court of Appeals for the Federal Circuit issued a mixed ruling in the long-running battle over Lipitor, the world’s best-selling drug.

The Federal Circuit’s ruling affirmed a lower court’s decision that a patent covering the drug that...
To view the full article, register now.